1. Home
  2. LKQ vs HALO Comparison

LKQ vs HALO Comparison

Compare LKQ & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LKQ Corporation

LKQ

LKQ Corporation

N/A

Current Price

$31.37

Market Cap

8.4B

ML Signal

N/A

Logo Halozyme Therapeutics Inc.

HALO

Halozyme Therapeutics Inc.

N/A

Current Price

$68.16

Market Cap

8.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LKQ
HALO
Founded
1998
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Motor Vehicles
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.4B
8.8B
IPO Year
2003
2001

Fundamental Metrics

Financial Performance
Metric
LKQ
HALO
Price
$31.37
$68.16
Analyst Decision
Buy
Buy
Analyst Count
6
11
Target Price
$42.33
$78.18
AVG Volume (30 Days)
1.9M
1.8M
Earning Date
05-22-2026
05-11-2026
Dividend Yield
3.81%
N/A
EPS Growth
N/A
N/A
EPS
2.35
2.56
Revenue
$13,651,000,000.00
$151,862,000.00
Revenue This Year
$2.01
$28.24
Revenue Next Year
$1.64
$12.79
P/E Ratio
$13.39
$26.28
Revenue Growth
N/A
N/A
52 Week Low
$28.13
$47.50
52 Week High
$44.30
$82.22

Technical Indicators

Market Signals
Indicator
LKQ
HALO
Relative Strength Index (RSI) 37.18 38.91
Support Level $29.30 $67.94
Resistance Level $32.08 $74.92
Average True Range (ATR) 1.13 2.36
MACD -0.29 -0.67
Stochastic Oscillator 23.72 17.13

Price Performance

Historical Comparison
LKQ
HALO

About LKQ LKQ Corporation

LKQ Corp is a world-wide distributor of vehicle products, including replacement parts, components and systems used in the repair and maintenance of vehicles, and specialty aftermarket products and accessories to improve the performance, functionality and appearance of vehicles. The company is organized into three operating segments: North America; Europe; and Specialty segment. It derives maximum revenue from Europe Segment. Europe segment is a provider of alternative vehicle replacement and maintenance products in Germany, the United Kingdom, the Benelux region (Belgium, Netherlands, and Luxembourg), Italy, Czech Republic, Austria, Slovakia, France and various other European countries.

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Share on Social Networks: